DPP4 and type 2 diabetes mellitus: Currently, there are several classes of orally administered pharmacological agents available for the therapy of type 2 diabetes, such as sulfonylureas, metformin, dipeptidyl peptidase IV (DPP-4) inhibitors and oral glucagon-like peptide 1 (GLP-1) receptor agonists [73].